Hung-Chih Hsu

10PUBLICATIONS
41CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsComparative language studies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 10, 2026
Optimizing third-line and beyond therapies for metastatic colorectal cancer in Taiwan: an evidence-based consensus.

|Jun 19, 2026
Trifluridine/tipiracil and survival in mismatch repair-deficient metastatic colorectal cancer.

|Apr 21, 2026
Amivantamab Monotherapy in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Results From OrigAMI-1, an Open-Label, Phase Ib/II Study.

|Feb 24, 2024
Association between personality types and low anterior resection syndrome in rectal cancer patients following surgery.

Ting-Yu Chiang, Yu-Jen Hsu, Yih-Jong Chern

|Mar 29, 2023
Skin Toxicity as a Predictor of Survival in Metastatic Colorectal Cancer Patients Treated with Anti-EGFR: Fact or Fallacy?

Ting-Yu Chiang, Hung-Chih Hsu, Yih-Jong Chern

|Aug 02, 2019
TP53 DNA Binding Domain Mutations Predict Progression-Free Survival of Bevacizumab Therapy in Metastatic Colorectal Cancer.

Hung-Chih Hsu, Jeng-Fu You, Shu-Jen Chen

Pageof 2

Frequent Collaborators

2 joint publications

Chia-Yen Hung

2 joint publications

Wen-Chi Chou

2 joint publications

Wen-Sy Tsai

2 joint publications

Pei-Hung Chang